SHAREHOLDER ALERT: Investigation of Harrow Health Announced by Holzer & Holzer, LLC

ATLANTA--()--Holzer & Holzer, LLC is investigating whether certain statements made by Harrow Health, Inc. (“Harrow Health” or the “Company”) (NASDAQ: HROW) complied with federal securities laws. On August 14, 2019, Harrow Health filed a form 10-Q with the SEC that disclosed its Park facility in California is required to surrender its California pharmacy license by August 27. The price of Harrow Health stock fell following the announcement.

If you purchased shares of Harrow Health and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Luke R. Kennedy at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Contacts

Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com

Release Summary

Holzer investigates Harrow Health

Contacts

Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com